Hylenex recombinant human hyaluronidase
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Hylenex recombinant human hyaluronidase, covering 2013-12-11 to 2025-09-15. Get the full timeline:
Most recent: Clinical Trial Update: S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration [Phase 3]